Drug Search Results
More Filters [+]

Propoxyphene napsylate

Alternative Names: propoxyphene napsylate, darvon-n, darvocet-n 100, darvocet-n 50, darvocet a500, propacet 100
Latest Update: 2023-04-25
Latest Update Note: News Article

Product Description

Propoxyphene napsylate differs from the hydrochloride salt in several ways. It is much less soluble and bitter and poses few stability problems when capsulated or tableted with aspirin.  (Sourced from: https://pubmed.ncbi.nlm.nih.gov/10824/)

Mechanisms of Action: OPRM Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: India | South Africa

Approved Indications: None

Known Adverse Events: None

Company: Xanodyne
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Propoxyphene napsylate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

XP20C-101

P4

Terminated

Healthy Volunteers

2010-11-01

Recent News Events